Operating Expenses

Impairment Charges

This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2018
Last reportedQ3 2026Feb 24, 2026

How to read this metric

An increase signals poor past investment decisions or deteriorating market conditions, which is generally viewed negatively by investors.

Detailed definition

These are non-cash charges recognized when the carrying value of an asset exceeds its fair market value. Such charges in...

Peer comparison

Common in large, diversified firms that frequently acquire or divest business units.

Metric ID: impairment_charges

Historical Data

15 periods
 Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26Q3 '26
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Range$0.00$0.00

Business Segments

View all
SegmentFY'22FY'23
Neuroscience$0.00$0.00
Total

All segment values are derived from annual filings.

Neuroscience was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.

Impairment Charges at Other Companies

Frequently Asked Questions

What is Medtronic's impairment charges?
Medtronic (MDT) reported impairment charges of $0.00 in Q4 2025.
What does impairment charges mean?
A write-down of the value of assets that are no longer worth what they are listed for.